Stockscreener 앱 받기
2.66
3.62%
-0.10
시간 외 거래:
2.68
0.02
+0.75%
전일 마감가:
$2.76
열려 있는:
$2.68
하루 거래량:
43,550
Relative Volume:
0.97
시가총액:
$39.79M
수익:
$37.79M
순이익/손실:
$-10.38M
주가수익비율:
-3.6438
EPS:
-0.73
순현금흐름:
$-1.00M
1주 성능:
-19.39%
1개월 성능:
-15.02%
6개월 성능:
-40.89%
1년 성능:
+133.33%
1일 변동 폭
$2.66
$2.855
1주일 범위
$2.64
$3.40
52주 변동 폭
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
명칭
Cumberland Pharmaceuticals Inc
전화
615-255-0068
주소
2525 WEST END AVENUE, NASHVILLE,, TN
CPIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
2.66 | 41.29M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2012-11-12 | 재확인 | UBS | Neutral |
| 2011-02-01 | 재확인 | UBS | Neutral |
| 2010-12-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2010-08-17 | 다운그레이드 | Jefferies | Buy → Hold |
| 2010-08-17 | 재확인 | Morgan Joseph | Buy |
| 2010-08-17 | 재확인 | UBS | Buy |
| 2010-05-14 | 재확인 | Morgan Joseph | Buy |
모두보기
Cumberland Pharmaceuticals Inc 주식(CPIX)의 최신 뉴스
Why Cumberland Pharmaceuticals Inc. stock is trending among retail tradersJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Why Cumberland Pharmaceuticals Inc. stock is rated strong buyQuarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com
Is Cumberland Pharmaceuticals Inc. stock safe for conservative investorsFed Meeting & Fast Gain Stock Tips - newser.com
Has Cumberland Pharmaceuticals Inc. formed a bullish divergenceEarnings Trend Report & Low Risk Entry Point Tips - newser.com
How to forecast Cumberland Pharmaceuticals Inc. trends using time series2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com
Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidanceJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com
[Form 4] CUMBERLAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Visual analytics tools that track Cumberland Pharmaceuticals Inc. performanceTreasury Yields & Weekly Market Pulse Updates - newser.com
Is Cumberland Pharmaceuticals Inc. stock trading near support levels2025 Price Targets & Long-Term Capital Growth Strategies - newser.com
Heatmap analysis for Cumberland Pharmaceuticals Inc. and competitors2025 Trading Volume Trends & Daily Stock Trend Watchlist - newser.com
Published on: 2025-11-03 00:44:08 - newser.com
Cumberland Pharmaceuticals Inc. stock outlook for YEARLayoff News & Verified Momentum Stock Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. a candidate for recovery play2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. forming a reversal patternBull Run & Safe Capital Growth Stock Tips - newser.com
Can Cumberland Pharmaceuticals Inc. stock sustain institutional interest2025 Market Outlook & High Yield Stock Recommendations - newser.com
Applying chart zones and confluence areas to Cumberland Pharmaceuticals Inc.Weekly Trading Summary & AI Enhanced Trading Signals - newser.com
Regression analysis insights on Cumberland Pharmaceuticals Inc. performance2025 Big Picture & Fast Gain Swing Alerts - newser.com
Cumberland Pharmaceuticals’ Promising Phase II Study on Ifetroban for IPF - MSN
Cumberland Pharmaceuticals (Nasdaq: CPIX) to Report Q3 2025 Results, Hosting Investor Call - Stock Titan
Will Cumberland Pharmaceuticals Inc. stock maintain growth storyEarnings Trend Report & Accurate Intraday Trade Tips - fcp.pa.gov.br
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE - Sahm
Cumberland Pharmaceuticals Inc (CPIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.60%
0.45%
자본화:
|
볼륨(24시간):